These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26847824)

  • 1. A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.
    López P; Rodríguez-Carrio J; Caminal-Montero L; Mozo L; Suárez A
    Sci Rep; 2016 Feb; 6():20651. PubMed ID: 26847824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
    López P; Scheel-Toellner D; Rodríguez-Carrio J; Caminal-Montero L; Gordon C; Suárez A
    Rheumatology (Oxford); 2014 Dec; 53(12):2249-58. PubMed ID: 24942493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased interferon-1α, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus.
    Fernández Matilla M; Grau García E; Fernández-Llanio Comella N; Chalmeta Verdejo I; Ivorra Cortés J; Castellano Cuesta JA; Román Ivorra JA
    Med Clin (Barc); 2019 Sep; 153(6):225-231. PubMed ID: 30795903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of BLyS on the activity of peripheral B lymphocytes mediated by BLyS receptors in patients with systemic lupus erythematosus.
    Cheng Y; Yan S; Zhao W; Huang Q; Lian L; Wei W
    Scand J Clin Lab Invest; 2013 Mar; 73(2):141-7. PubMed ID: 23336587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.
    Ritterhouse LL; Crowe SR; Niewold TB; Merrill JT; Roberts VC; Dedeke AB; Neas BR; Thompson LF; Guthridge JM; James JA
    Arthritis Rheum; 2011 Dec; 63(12):3931-41. PubMed ID: 22127709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.
    Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A
    Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.
    Collins CE; Gavin AL; Migone TS; Hilbert DM; Nemazee D; Stohl W
    Arthritis Res Ther; 2006; 8(1):R6. PubMed ID: 16356193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high-mobility group box 1 is correlated with interferon-α and may predict disease activity in patients with systemic lupus erythematosus.
    Tanaka A; Ito T; Kibata K; Inagaki-Katashiba N; Amuro H; Nishizawa T; Son Y; Ozaki Y; Nomura S
    Lupus; 2019 Aug; 28(9):1120-1127. PubMed ID: 31299881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between FOXP3 positive populations and cytokine production in systemic lupus erythematosus.
    Prado C; de Paz B; López P; Gómez J; Rodríguez-Carrio J; Suárez A
    Cytokine; 2013 Jan; 61(1):90-6. PubMed ID: 23022375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.
    Hong SD; Reiff A; Yang HT; Migone TS; Ward CD; Marzan K; Shaham B; Phei WC; Garza J; Bernstein B; Stohl W
    Arthritis Rheum; 2009 Nov; 60(11):3400-9. PubMed ID: 19877053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suárez A
    Int J Cardiol; 2017 Jun; 236():138-144. PubMed ID: 28279502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients.
    Robak E; Kulczycka-Siennicka L; Gerlicz Z; Kierstan M; Korycka-Wolowiec A; Sysa-Jedrzejowska A
    Eur Cytokine Netw; 2013 Mar; 24(1):60-8. PubMed ID: 23661335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drugs inhibit IFNα-enhanced TNFα and STAT4 expression in monocytes: implication for systemic lupus erythematosus.
    López P; Rodríguez-Carrio J; Suárez A
    Cytokine; 2014 May; 67(1):13-20. PubMed ID: 24680477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus.
    Mohammadi S; Ebadpour MR; Sedighi S; Saeedi M; Memarian A
    Clin Rheumatol; 2017 Aug; 36(8):1765-1772. PubMed ID: 28601944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.
    Carter RH; Zhao H; Liu X; Pelletier M; Chatham W; Kimberly R; Zhou T
    Arthritis Rheum; 2005 Dec; 52(12):3943-54. PubMed ID: 16320342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.